Daniel M Bollag Net Worth & Insider Trades

Daniel M Bollag - Sr. VP Reg. Affairs & Quality, Ocular Therapeutix, Inc

As of January 4, 2019

What is Daniel M Bollag's Net Worth?

The current estimated net worth of Ocular Therapeutix, Inc's Sr. VP Reg. Affairs & Quality, Daniel M Bollag, is estimated to be about $4.27M . Daniel M Bollag owns about 42,100 units of Ocular Therapeutix, Inc common stock. In the last 2 years at Ocular Therapeutix, Inc, Daniel M Bollag has sold an estimated value of $0 worth.

What is Daniel M Bollag's Past Insider Trading?

Daniel M Bollag's largest purchase order was 17,400 units , worth over $100.22K on December 10, 2018. In total, Daniel M Bollag has made about 5 transactions over 2 years of their time at Ocular Therapeutix, Inc. Daniel M Bollag usually trades in December, with the busiest year in 2017 and 2018.

Daniel M Bollag
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Daniel M Bollag's' Mailing Address?

  • Mailing address is C/o Ariad Pharmaceuticals, Inc. 26 Landsdowne Street Cambridge MA 02139 MA

Ocular Therapeutix, Inc Executive Compensation

Name
Year
Salary
Total
Antony Mattessich 2020 $600,000 $2,163,150
Antony Mattessich 2019 $581,796 $2,126,146
Michael Goldstein, M.D. 2020 $440,000 $1,336,250
Michael Goldstein, M.D. 2019 $423,906 $1,007,731
Philip C. Strassburger, Esq. 2020 $125,592 $2,413,764
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1393434/000155837021005257/tmb-20210618xdef14a.htm

What are Ocular Therapeutix, Inc's Past Insider Trades?

Ocular Therapeutix, Inc's most recent insider trade came on May 16, 2022 by Jeffrey S Heier who bought 15,000 units worth $45.75K . In the last 8 years, insiders at Ocular Therapeutix, Inc have sold an estimated value of $72.54M and bought an estimated value of $26.53M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Amarpreet Sawhney, Chairman the Board,  Charles M Warden, Director,  and Richard L. Lindstrom, M.D., Director .

OCULAR THERAPEUTIX, INC Insider Trades
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1